The National Neurotrauma Society 30th Annual Conference (Phoenix July 22-25,2012)

描述(申请人提供)：此资助申请是为了部分支持全国神经创伤学会在亚利桑那州菲尼克斯的比尔特莫尔度假村举行的S第30届年会。今年的年会从2012年7月22日至25日举行，为期三天半，有22个令人兴奋的会议，包括六个平行的会议，涵盖临床前和临床研究的平衡 无论是创伤性脑损伤还是脊髓损伤。在这份申请中，我们为20名最优秀的博士后和博士后学生(10,000美元)提供出席会议的资金支持，并为30名受邀演讲者的旅费提供15,000美元的部分支持。今年会议的主题是“神经创伤的光谱”--我们将集中讨论神经创伤中几个相互关联和热门的问题。在颅脑损伤分区中，儿童脑损伤是研究不足的领域之一，这将在本次会议上介绍。另一方面，在过去的一年里，我们继续看到人们对冲击性脑损伤的兴趣和出版物的爆炸性增长(Scheibel等人，2011年；Bass等人，2011年)，这些将在会议上亮相。关于脊髓损伤(SCI)，将有一个关于脊髓损伤后各种功能缺陷和并发症的会议。在神经创伤的管理和治疗方面，我们将提供生物标志物和新的MRI成像技术的最新应用概述，承诺进行临床前药物治疗，并更新正在进行的脑损伤和脊髓损伤的临床试验，包括正在进行的两项黄体酮试验。我们还将涵盖神经创伤不仅是一个急性医疗问题，而且可能演变为患者的慢性医疗状况的概念。因此，神经康复方面更复杂的研究和临床工具将是关键，理解从脑外伤到阿尔茨海默氏症和慢性创伤性脑病(CTE)等慢性神经退行性疾病的分子进化也是关键(Stern等人，2011年)。最后，我们还将邀请几位国际演讲者谈谈他们在本国的TBI管理经验，以供交叉学习。 与公共卫生相关：我们预计将有700多名与会者(包括医生、护士、神经心理学家和研究人员(医学博士、博士、教授、博士后和研究生)参加在亚利桑那州凤凰城举行的全国神经创伤学会第30届年会(2012年7月)美国急诊室收到的创伤性脑损伤新病例超过150万例，每年超过50,000例死亡。此外，每年约有12,000例新的脊髓损伤发生。今年会议的主题是“神经创伤的光谱”。

DESCRIPTION (provided by applicant): This grant application is to support in part the National Neurotrauma Society (NNS)'s 30th Annual Conference at the Arizona Biltmore Resort, Phoenix AZ. This year's three and a half day conference from July 22-25, 2012 has 22 exciting sessions, including six parallel sessions that cover a balance of preclinical and clinical research on both traumatic brain and spinal cord injury. In this application, we seek funding support for the 20 best pre and post -doctoral students ($10,000), to attend the meeting, and $15,000 towards partial support for the travel of 30 invited speakers. The theme of this year's conference is "The Spectrum of Neurotrauma" - we will focus on several interlinked and topical issues in neurotrauma. In the TBI subarea, one of the understudied areas is pediatric brain injury, which will be featured in this conference. On the other hand, during this past year, we continue to see an explosion of interests and publications in blast brain injury (Scheibel, et al., 2011; Bass et a., 2011) which will be featured in the conference. Regarding spinal cord injury (SCI), there will be a focused session on various functional deficits and complications after SCI. In terms of neurotrauma management and treatment, we will provide state-of-the-art overviews of the utility of biomarkers and new MRI imaging technology, promising preclinical drug treatment and update of on-going clinical trials in TBI and SCI, including the two on-going progesterone trials. We will also cover the concept that neurotrauma is not only an acute medical problem, but can evolve into a chronic medical condition for the patients. Thus more sophisticated research and clinical tools in neuro-rehabilitation will be the key, as is the understanding of the molecular evolution from TBI to chronic neurodegenerative diseases such as Alzheimer's and Chronic Traumatic Encephalopathy (CTE) (Stern et al., 2011). Lastly, we will also invite several international speakers to talk about their TBI management experience in their own countries for cross-learning. PUBLIC HEALTH RELEVANCE: We expect to have 700 plus attendees including (physicians, nurses, neuropsychologist and researchers (MD, PhD, professors, postdocs and graduate students) attending the National Neurotrauma Society's 30th Annual Conference in Phoenix AZ (July 2012) Over 1.5 million new cases of traumatic brain injury present to emergency rooms in the United States and over 50,000 die each year. In addition, approximately 12,000 new spinal cord injuries occur each year. The theme of this year's conference is "The Spectrum of Neurotrauma".